investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Analyzing Weybosset Research & Management LLC’s Portfolio Changes from Q4 2022 to Q1 2023: Notable Investments and Potential Factors Behind Holdings Shifts

Ava Hoppe | 18 April, 2023

Weybosset Research & Management LLC, a registered investment firm that provides investment advice to clients, recently filed its 13F form with the US Securities and Exchange Commission (SEC) for Q4 2022 and Q1 2023. The 13F form is a quarterly report that institutional investment managers with over $100 million in assets under management are required to file, disclosing their holdings in publicly traded companies. The report provides investors with a valuable insight into the investment strategies of these large institutional investors and can be used as a tool to analyze the market trends.

This blog post will analyze the changes in holdings of Weybosset Research & Management LLC’s portfolio from Q4 2022 to Q1 2023, highlighting notable changes in their investments, and exploring the potential reasons behind these shifts in holdings.

Notable Investments

One of the notable changes in holdings in Weybosset Research & Management LLC’s portfolio from Q4 2022 to Q1 2023 is their increase in holdings of Copart Inc (CPRT). Weybosset Research & Management LLC increased its holdings of CPRT by 21.4%, holding 383,776 shares in the company by the end of Q4 2022 and 377,211 shares by the end of Q1 2023. The value of the holdings in the company also increased from $23,368,000 to $28,370,000 during this period.

Another interesting change in holdings is in Johnson & Johnson (JNJ), where Weybosset Research & Management LLC decreased its holdings by 12.7%, holding 57,986 shares in the company by the end of Q4 2022, and 57,691 shares by the end of Q1 2023. The value of the holdings in the company also decreased from $10,243,000 to $8,942,000 during this period.

Other changes in holdings worth noting include:

- A decrease in holdings of Illinois Tool Works Inc (ITW) by 33%, holding 1,910 shares by the end of Q4 2022, and 1,375 shares by the end of Q1 2023. The value of the holdings in the company decreased from $500,000 to $335,000 during this period.

- An increase in holdings of Salesforce Inc (CRM) by 54.5%, holding 1,575 shares by the end of Q4 2022, and 1,615 shares by the end of Q1 2023. The value of the holdings in the company increased from $209,000 to $323,000 during this period.

- An increase in holdings of Apple Inc (AAPL) by 29.6%, holding 12,411 shares by the end of Q4 2022, and 12,679 shares by the end of Q1 2023. The value of the holdings in the company increased from $1,613,000 to $2,091,000 during this period.

Potential Reasons for the Changes in Holdings

There are a variety of reasons why institutional investors like Weybosset Research & Management LLC might shift their holdings in a certain company or sector. One possible factor that might have driven Weybosset Research & Management LLC’s increase in holdings of Copart Inc, for example, is the recent announcement of the company’s strong Q1 2023 results. The company reported a 17.6% increase in revenue year-over-year, along with an increase in gross profit and net income. Additionally, the company’s strong free cash flow generation has enabled it to continue repurchasing its shares, which could explain why Weybosset Research & Management LLC has increased its holding in the company.

On the other hand, the reason behind Weybosset Research & Management LLC’s decrease in holdings of Johnson & Johnson may be due to the company’s recent legal troubles. The pharmaceutical giant has faced several high-profile lawsuits, including one claiming that the company was responsible for fueling the opioid epidemic. Additionally, the company has faced criticism for its handling of recalls of its talc-based baby powder, which has been linked to cases of cancer. Weybosset Research & Management LLC may have chosen to decrease its holdings in the company because of these ongoing legal issues, which might negatively impact the company’s financial performance.

Conclusion

In conclusion, Weybosset Research & Management LLC’s 13F filing for Q4 2022 and Q1 2023 reveals several notable changes in the company’s portfolio. While the exact reasons behind these changes in holdings are not always clear, investors can analyze the reported data and make informed judgments about why Weybosset Research & Management LLC may have shifted its holdings in certain companies or sectors. Ultimately, these 13F filings can provide valuable insights for investors seeking to understand the investment strategies of large institutional investors like Weybosset Research & Management LLC.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.